Latest Noritate Stories
Health Canada Approves The First and Only Topical Treatment Indicated for the Persistent Facial Erythema of Rosacea THORNHILL, ON, May 21, 2014 /CNW/ - Galderma Canada Inc., today announced that ONRELTEA(TM) topical gel (Brimonidine gel 0.33%) has been approved by Health Canada and is now available for Canadian patients 18 and older to treat the facial erythema (redness) of rosacea. ONRELTEA is the first and only Health Canada-approved topical prescription specifically designed to...
- A stinking tobacco.
- Offal; waste animal product; organic matter unfit for consumption.